-
Pharmaceutical sector's investment in Canada chronically underreported: KPMG
OTTAWA | For the third consecutive year, a KPMG study commissioned by Canada's Research-Based Pharmaceutical Companies (Rx&D) has determined that research and development investments made by Canada's innovative pharmaceutical sector continue to be consistently underreported, by approximately 34% for 2012. -
Funding awarded for 17 genomic research projects
OTTAWA | New Canadian bioinformatics and computational biology research projects will help manage, analyze and interpret vast amounts of genomics data to accelerate advances in personalized medicine, public health and other areas of importance to Canadians and the economy